• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Summit Biosciences wins EU nod to manufacture prescription nasal sprays

September 14, 2017 By Sarah Faulkner

Summit BiosciencesSummit Biosciences said today that it won a certificate of GMP compliance from the Medicines and Healthcare Products Regulatory Agency on behalf of the European Medicines Agency.

The decision comes after a successful inspection of the company’s manufacturing plant in Kentucky.

The certificate allows Summit to produce prescription nasal spray products to be exported to its customers in Europe. The company said that the move is in anticipation of the European launch of a prefilled, single-dose, intranasal product from an undisclosed international client.

“I applaud our entire team for their dedication to regulatory excellence and this outstanding achievement,” founder & CEO Edwin Cohen said in prepared remarks.

“The company’s unwavering commitment to Current Good Manufacturing Practices provides confidence to customers, doctors, and their patients that our products are manufactured under strict adherence to the highest level of quality standards no matter where they are sold,” COO Greg Plucinski added.

The privately-held pharmaceutical company, based on the Coldstream Research Campus at the University of Kentucky, develops, manufactures and commercializes prescription and over-the-counter sublingual and nasal spray products.

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: summitbiosciences

IN CASE YOU MISSED IT

  • Flat Medical partners with Mercury Medical on smart syringe distribution
  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS